Methylxanthines, Seizures, and Excitotoxicity
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Clinical evidence, in particular the wide use of theophylline as bronchodilator, suggests that methylxanthines can cause seizures in patients without known underlying epilepsy. Theophylline is also known to be an added risk factor for seizure exacerbation in patients with epilepsy. The proconvulsant activity of methylxanthines can best be explained by antagonizing the brain’s own anticonvulsant adenosine. Recent evidence suggests that adenosine dysfunction is a pathological hallmark of epilepsy contributing to seizure generation and seizure spread. Conversely, adenosine augmentation therapies are effective in seizure suppression and prevention, whereas adenosine receptor antagonists such as methylxanthines generally exacerbate seizures. The impact of the methylxanthines caffeine and theophylline on seizures and excitotoxicity depends on timing, dose, and acute versus chronic use. New findings suggest a role of free radicals in theophylline-induced seizures and adenosine-independent mechanisms for seizure generation have been proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 3×
“GABAA receptor and phosphodiesterase (PDE) inhibition In contrast to adenosine receptors, which are affected by caffeine plasma concentrations attainable by normal human caffeine consumption, 10 to 100 times higher concentrations are needed to inhibit GABAARs or PDE (Fredholm et al. 1999).”
BackgroundFick, D. M., Cooper, J. W., Wade, W. E., Waller, J. L., Maclean, J. R., & Beers, M. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.22.2716 · Cited by 2,389 · cited 1×
“Due to concerns of CNS stimulant effects, theophylline use in patients with insomnia has been included in the 2002 Criteria for Potentially Inappropriate Medication Use in Older Adults (Fick et al. 2003).”
BackgroundAdenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431 · cited 1×
“Conversely, A1R agonists are highly effective in the suppression of seizures (Benarroch 2008; Fredholm 2003; Jacobson and Gao 2006), and have been demonstrated to suppress seizures that are resistant to conventional antiepileptic”
BackgroundAstrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280 · cited 1×
“Under physiological conditions, synaptic adenosine is largely derived from vesicular release of ATP from astrocytes followed by extracellular cleavage into adenosine (Pascual et al. 2005), although astrocytic release of ATP via hemichannels has been demonstrated (Iglesias et al.”
BackgroundDiabetic Neuropathy: An intensive review
Duby, J. J., Campbell, R. K., Setter, S. M., White, J. R., & Rasmussen, K. A. (2004) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/61.2.160 · Cited by 382
Adenosine: does it have a neuroprotective role after all?
de Mendonça, A., Sebastião, A. M., & Ribeiro, J. A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00033-3 · Cited by 248 · cited 2×
“Effect inversion of chronic adenosine receptor antagonists has also been described within the context of ischemic excitotoxicity ( de Mendonca et al.2000 ).”
BackgroundJohansson, B., Ahlberg, S., van der Ploeg, I., Brené, S., Lindefors, N., Persson, H., & Fredholm, B. B. (1993) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00165391 · Cited by 144 · cited 1×
“In contrast, higher plasma concentrations of caffeine (100 mM) after chronic dosage for 12 days resulted in increased A1R densities, whereas messenger RNA levels or A2ARs were not affected (Johannson et al. 1993).”
Background
Cited by
A Review of Caffeine’s Effects on Cognitive, Physical and Occupational Performance
McLellan, T. M., Caldwell, J. A., & Lieberman, H. R. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.09.001 · Cited by 840
“…its inhibitory effects on serotonin release Mahoney et al., 2011), and methylxanthines, such as theophylline nd caffeine, have been implicated in lowering the epileptic seizure hreshold through antagonism of adenosine on glutamatergic neuons (Boison, 2011; Dunwiddie, 1980; Fukuda et al., 2010).”
BackgroundMolecular mechanisms of epilepsy
Staley, K. (2015) · Nature Neuroscience · doi:10.1038/nn.3947 · Cited by 376
The metabolic basis of epilepsy
Rho, J. M., & Boison, D. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00651-8 · Cited by 295
Self-citationThe clinical toxicology of caffeine: A review and case study
Willson, C. (2018) · Toxicology Reports · doi:10.1016/j.toxrep.2018.11.002 · Cited by 289
Astrocytes in the initiation and progression of epilepsy
Vezzani, A., Ravizza, T., Bedner, P., Aronica, E., Steinhäuser, C., & Boison, D. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00727-5 · Cited by 272
Self-citation
Metadata
- Authors
- Boison, D.
- Venue
- Handbook of Experimental Pharmacology
- Publisher
- Springer Berlin Heidelberg
- Published
- 2010-08-19
- Issue
- 200
- Pages
- 251-266
- ISSN
- 0171-2004 (ISSN-L)
- 1865-0325
- OpenAlex
- W1585469811
- Cited by
- 89
- References
- 7
- FWCI
- 25.34
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Methylxanthines, Seizures, and Excitotoxicity. https://app.cochat.ai/papers/10.1007/978-3-642-13443-2_9
- The paper
- Boison, D. (2011). Methylxanthines, Seizures, and Excitotoxicity. Handbook of Experimental Pharmacology. https://doi.org/10.1007/978-3-642-13443-2_9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.